Broadlane cuts deals with R2 and Varian
Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The
Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The exclusive agreement with R2, which extends to Dec. 31, 2004, provides access for Broadlane customers to R2's ImageChecker CAD mammography system. Varian will offer Broadlane institutions a range of radiotherapy products including its Clinac medical linear accelerators, Millennium multileaf collimators, and PortalVision electronic portal imaging systems. Broadlane customers will also have access to imaging products from GE Medical Systems that Varian distributes in North America under a special See and Treat Cancer Care partnership agreement.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
